Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Baum

Showing results (61-70 of 143) with videos related to

Pageof 15
Sort By:
Human Gene Therapy|August 12, 2003
Retroviral vectors for high-level transgene expression in T lymphocytesBoris Engels, Hakan Cam, Thomas Schüler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 18, 2009
Cell-intrinsic and vector-related properties cooperate to determine the incidence and consequences of insertional mutagenesisOlga S Kustikova, Bernhard Schiedlmeier, Martijn H Brugman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 18, 2005
Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cellsAxel Schambach, Jens Bohne, Saurabh Chandra, et al.
Blood|January 4, 2003
Side effects of retroviral gene transfer into hematopoietic stem cellsChristopher Baum, Jochen Düllmann, Zhixiong Li, et al.
Journal of Hepatology|July 14, 2006
In vivo selection of transduced hematopoietic stem cells and little evidence of their conversion into hepatocytes in vivoKanji Yamaguchi, Katsuhiko Itoh, Tomoko Masuda, et al.
European Journal of Haematology|May 30, 2012
Angptl4 maintains in vivo repopulation capacity of CD34+ human cord blood cellsUlrika Blank, Birgitta Ehrnström, Niels Heinz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 13, 2008
Physiological promoters reduce the genotoxic risk of integrating gene vectorsDaniela Zychlinski, Axel Schambach, Ute Modlich, et al.
Nucleic Acids Research|June 13, 2002
Unmodified Cre recombinase crosses the membraneElke Will, Hannes Klump, Nicole Heffner, et al.
Blood|July 26, 2003
Dose finding with retroviral vectors: correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell populationOlga S Kustikova, Anke Wahlers, Klaus Kuhlcke, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 13, 2008
Stem cell marking with promotor-deprived self-inactivating retroviral vectors does not lead to induced clonal imbalanceKerstin Cornils, Claudia Lange, Axel Schambach, et al.
Pageof 15

Showing results (61-70 of 143) with videos related to

Sort By:
Pageof 15
Human Gene Therapy|August 12, 2003
Retroviral vectors for high-level transgene expression in T lymphocytesBoris Engels, Hakan Cam, Thomas Schüler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 18, 2009
Cell-intrinsic and vector-related properties cooperate to determine the incidence and consequences of insertional mutagenesisOlga S Kustikova, Bernhard Schiedlmeier, Martijn H Brugman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 18, 2005
Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cellsAxel Schambach, Jens Bohne, Saurabh Chandra, et al.
Blood|January 4, 2003
Side effects of retroviral gene transfer into hematopoietic stem cellsChristopher Baum, Jochen Düllmann, Zhixiong Li, et al.
Journal of Hepatology|July 14, 2006
In vivo selection of transduced hematopoietic stem cells and little evidence of their conversion into hepatocytes in vivoKanji Yamaguchi, Katsuhiko Itoh, Tomoko Masuda, et al.
European Journal of Haematology|May 30, 2012
Angptl4 maintains in vivo repopulation capacity of CD34+ human cord blood cellsUlrika Blank, Birgitta Ehrnström, Niels Heinz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 13, 2008
Physiological promoters reduce the genotoxic risk of integrating gene vectorsDaniela Zychlinski, Axel Schambach, Ute Modlich, et al.
Nucleic Acids Research|June 13, 2002
Unmodified Cre recombinase crosses the membraneElke Will, Hannes Klump, Nicole Heffner, et al.
Blood|July 26, 2003
Dose finding with retroviral vectors: correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell populationOlga S Kustikova, Anke Wahlers, Klaus Kuhlcke, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 13, 2008
Stem cell marking with promotor-deprived self-inactivating retroviral vectors does not lead to induced clonal imbalanceKerstin Cornils, Claudia Lange, Axel Schambach, et al.
Pageof 15